A study conducted by Zegami, a data visualisation spin-out from Oxford University, has found that there are at least 34 ongoing COVID-19 projects from European medtechs which are looking to support healthcare professionals.
Zegami, which is among those working on a COVID-19-related project, conducted the study via Google searches and contact with figures in the medtech industry in Europe.
Of the 34 companies identified, 11 of those are UK-based, followed by Switzerland, which has four medtech companies working on COVID-19 projects, and Sweden, which has three projects ongoing.
Zegami founder and CEO Roger Noble commented on the study’s findings: “It is very encouraging to see such a positive and proactive response from Europe’s startup medtech sector in the fight against COVID-19. Many, like us, are also providing their services for free. There is little doubt that the industry has a huge role to play in defeating this disease.”
Zegami’s project is using X-rays of the lungs of patients infected with COVID-19 to build a robust machine learning model which will be able to assist healthcare professionals in identifying cases of the virus.
The company’s proof of concept diagnostic tool is able to differentiate between COVID-19 and other forms of pneumonia with at least 70 per cent accuracy. Zegami hopes to build a system that achieves greater accuracy and has the potential to identify conditions and produce predictions on patient outcomes.